Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cholinesterase Inhibitors | 3 | 2018 | 99 | 2.04 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 5 | 2019 | 1261 | 1.74 | Why? |
| Inappropriate Prescribing | 3 | 2019 | 284 | 1.69 | Why? |
| Dementia | 6 | 2019 | 1861 | 1.62 | Why? |
| Ontario | 19 | 2021 | 1966 | 1.49 | Why? |
| Drug Prescriptions | 4 | 2021 | 1062 | 1.20 | Why? |
| Patient Transfer | 3 | 2020 | 898 | 0.98 | Why? |
| Nursing Homes | 9 | 2021 | 4155 | 0.84 | Why? |
| Restraint, Physical | 1 | 2019 | 74 | 0.76 | Why? |
| Benzodiazepines | 2 | 2018 | 163 | 0.75 | Why? |
| Long-Term Care | 4 | 2021 | 2047 | 0.71 | Why? |
| Terminal Care | 2 | 2019 | 928 | 0.70 | Why? |
| Data Interpretation, Statistical | 2 | 2020 | 657 | 0.69 | Why? |
| Unnecessary Procedures | 1 | 2019 | 175 | 0.68 | Why? |
| Analgesics, Opioid | 2 | 2017 | 1070 | 0.66 | Why? |
| Serotonin Uptake Inhibitors | 1 | 2018 | 149 | 0.64 | Why? |
| Parkinsonian Disorders | 1 | 2018 | 118 | 0.64 | Why? |
| Carcinoma, Basal Cell | 1 | 2018 | 144 | 0.62 | Why? |
| Sex Distribution | 2 | 2020 | 2083 | 0.61 | Why? |
| Polypharmacy | 1 | 2019 | 347 | 0.61 | Why? |
| Homes for the Aged | 4 | 2019 | 1071 | 0.59 | Why? |
| Physicians, Primary Care | 1 | 2018 | 298 | 0.57 | Why? |
| Drug Utilization | 1 | 2019 | 619 | 0.53 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.52 | Why? |
| Demography | 1 | 2020 | 1660 | 0.52 | Why? |
| Publications | 1 | 2018 | 463 | 0.51 | Why? |
| Sex Factors | 7 | 2020 | 11014 | 0.50 | Why? |
| Antidepressive Agents | 1 | 2018 | 509 | 0.50 | Why? |
| Antipsychotic Agents | 2 | 2018 | 887 | 0.48 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 3832 | 0.46 | Why? |
| Research Design | 2 | 2017 | 5830 | 0.42 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.39 | Why? |
| Loneliness | 1 | 2021 | 1766 | 0.36 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.36 | Why? |
| Emigrants and Immigrants | 1 | 2017 | 888 | 0.35 | Why? |
| Heart | 1 | 2017 | 1791 | 0.34 | Why? |
| Drug Therapy | 1 | 2008 | 280 | 0.31 | Why? |
| Hip Fractures | 1 | 2014 | 667 | 0.30 | Why? |
| Emergency Service, Hospital | 4 | 2018 | 14232 | 0.30 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.29 | Why? |
| Aged, 80 and over | 18 | 2021 | 88759 | 0.29 | Why? |
| Activities of Daily Living | 1 | 2014 | 1530 | 0.29 | Why? |
| Opioid-Related Disorders | 1 | 2017 | 1185 | 0.28 | Why? |
| Skin Neoplasms | 1 | 2018 | 1679 | 0.28 | Why? |
| Aging | 1 | 2020 | 3581 | 0.27 | Why? |
| Pharmaceutical Preparations | 1 | 2018 | 1897 | 0.26 | Why? |
| Databases, Factual | 3 | 2019 | 6248 | 0.26 | Why? |
| Practice Patterns, Physicians' | 2 | 2019 | 4927 | 0.25 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.25 | Why? |
| Aged | 23 | 2021 | 215776 | 0.25 | Why? |
| Organ Transplantation | 1 | 2018 | 2616 | 0.25 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.24 | Why? |
| Dermatology | 1 | 2018 | 1999 | 0.24 | Why? |
| Breast Neoplasms | 2 | 2017 | 3633 | 0.23 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.23 | Why? |
| Propensity Score | 3 | 2018 | 2690 | 0.21 | Why? |
| Trazodone | 1 | 2018 | 6 | 0.20 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.19 | Why? |
| Female | 26 | 2021 | 380317 | 0.19 | Why? |
| Administrative Claims, Healthcare | 1 | 2018 | 124 | 0.19 | Why? |
| Authorship | 1 | 2021 | 240 | 0.18 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.18 | Why? |
| Hospitalization | 7 | 2020 | 54280 | 0.18 | Why? |
| Deprescriptions | 1 | 2019 | 294 | 0.17 | Why? |
| Male | 23 | 2021 | 367725 | 0.17 | Why? |
| Retrospective Studies | 14 | 2020 | 105322 | 0.17 | Why? |
| Humans | 37 | 2021 | 930598 | 0.17 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.17 | Why? |
| Proportional Hazards Models | 3 | 2018 | 6543 | 0.17 | Why? |
| Environment Design | 1 | 2018 | 183 | 0.16 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.16 | Why? |
| Transitional Care | 1 | 2018 | 135 | 0.16 | Why? |
| Pregnancy Complications, Neoplastic | 1 | 2017 | 79 | 0.16 | Why? |
| Cross-Sectional Studies | 7 | 2021 | 53120 | 0.15 | Why? |
| Journal Impact Factor | 1 | 2017 | 134 | 0.15 | Why? |
| Conservative Treatment | 1 | 2018 | 349 | 0.15 | Why? |
| Physicians, Family | 1 | 2018 | 208 | 0.14 | Why? |
| Gender Identity | 1 | 2017 | 262 | 0.14 | Why? |
| Specialization | 1 | 2018 | 432 | 0.14 | Why? |
| Risk-Taking | 1 | 2018 | 508 | 0.14 | Why? |
| Walking | 1 | 2018 | 442 | 0.13 | Why? |
| Cardiotoxicity | 1 | 2017 | 365 | 0.13 | Why? |
| Accidental Falls | 1 | 2018 | 448 | 0.13 | Why? |
| Peer Review, Research | 1 | 2017 | 407 | 0.13 | Why? |
| Palliative Care | 2 | 2019 | 2665 | 0.13 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.12 | Why? |
| Attitude | 1 | 2021 | 1481 | 0.11 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.11 | Why? |
| Health Services for the Aged | 1 | 2018 | 602 | 0.11 | Why? |
| Antimicrobial Stewardship | 1 | 2019 | 931 | 0.11 | Why? |
| Independent Living | 1 | 2017 | 842 | 0.11 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.10 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.10 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.10 | Why? |
| Registries | 3 | 2018 | 12327 | 0.09 | Why? |
| Patient Readmission | 1 | 2018 | 1543 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Periodicals as Topic | 1 | 2021 | 1492 | 0.09 | Why? |
| Cohort Studies | 3 | 2017 | 36005 | 0.09 | Why? |
| Residence Characteristics | 1 | 2018 | 1927 | 0.09 | Why? |
| Research Personnel | 1 | 2017 | 1037 | 0.08 | Why? |
| Continuity of Patient Care | 1 | 2017 | 1574 | 0.08 | Why? |
| Middle Aged | 8 | 2020 | 270681 | 0.08 | Why? |
| Frailty | 1 | 2018 | 1432 | 0.08 | Why? |
| Time | 1 | 2008 | 631 | 0.08 | Why? |
| Observational Studies as Topic | 1 | 2014 | 1887 | 0.08 | Why? |
| Parkinson Disease | 1 | 2018 | 1414 | 0.08 | Why? |
| Patient Discharge | 2 | 2018 | 5696 | 0.07 | Why? |
| Efficiency | 1 | 2008 | 420 | 0.07 | Why? |
| Depression | 2 | 2021 | 14116 | 0.07 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.07 | Why? |
| Adult | 7 | 2020 | 244371 | 0.07 | Why? |
| Risk | 1 | 2017 | 5288 | 0.07 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.07 | Why? |
| Anxiety | 2 | 2021 | 17311 | 0.07 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.06 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2017 | 2320 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2021 | 43792 | 0.06 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.06 | Why? |
| Brief Psychiatric Rating Scale | 1 | 2021 | 30 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.06 | Why? |
| Hospital Units | 1 | 2008 | 1017 | 0.06 | Why? |
| Safety | 1 | 2008 | 1583 | 0.05 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.05 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.05 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| Ownership | 1 | 2020 | 169 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Infant | 1 | 2020 | 30274 | 0.04 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.04 | Why? |
| Multimorbidity | 1 | 2020 | 703 | 0.04 | Why? |
| Off-Label Use | 1 | 2019 | 553 | 0.04 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Postpartum Period | 1 | 2017 | 936 | 0.03 | Why? |
| China | 1 | 2017 | 50654 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Frail Elderly | 1 | 2018 | 1427 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Canada | 1 | 2021 | 6018 | 0.02 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2021 | 3543 | 0.02 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |